Abstract
The activity of regulatory T cells (T-reg) is responsible for controlling aberrant immune responses and autoimmunity, but these cells represent a potential barrier to certain types of therapeutic manipulation, such as in cancer immunotherapy. Peng
et al
. provide evidence that part of human T-reg control may be mediated directly by an innate signaling protein. Clones of human T-reg, as well as isolated naturally occurring T-reg cells, expressed Toll-like receptor (TLR) 8. Ligands that could activate this receptor reversed the suppressive activity of these cells in culture, as well as in a mouse tumor model. Control over T-reg activity by TLR signals may open new avenues for inhibiting unwanted immune suppression during cancer immunotherapy.
G. Peng, Z. Guo, Y. Kiniwa, K. s. Voo, W. Peng, T. Fu, D. Y. Wang, Y. Li, H. Y. Wang, R.-F. Wang, Toll-like receptor 8-mediated reversal of CD4
+
regulatory T cell function.
Science
309
, 1380-1384 (2005).
[Abstract]
[Full Text]
Publisher
American Association for the Advancement of Science (AAAS)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献